Review



calu 6 lung xenograft efficacy model  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC calu 6 lung xenograft efficacy model
    Calu 6 Lung Xenograft Efficacy Model, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 549 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/calu+6+lung+xenograft+efficacy+model/Calu-6/us12558345-291-16-25
    Average 96 stars, based on 549 article reviews
    calu 6 lung xenograft efficacy model - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    In Vivo:

    Article Title: CHK1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas
    Article Snippet: .. The ability of CHK1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, NJ), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, MA).

    Article Title: 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
    Article Snippet: .. The ability of Chk1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, N.J.), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, Mass.).

    Article Title: CHK1/2 inhibitors and irinotecan for use in the treatment of rhabdomyosarcoma
    Article Snippet: .. The ability of CHK1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, N.J.), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, Mass.).

    Cell Culture:

    Article Title: CHK1/2 inhibitors for use in the treatment of neuroblastomas and/or soft tissue sarcomas
    Article Snippet: .. The ability of CHK1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, NJ), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, MA).

    Article Title: 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
    Article Snippet: .. The ability of Chk1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, N.J.), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, Mass.).

    Article Title: CHK1/2 inhibitors and irinotecan for use in the treatment of rhabdomyosarcoma
    Article Snippet: .. The ability of CHK1 inhibitors to effect tumor killing can be determined in vivo using the Calu-6 lung xenograft efficacy model. Calu-6 lung cancer cells (ATCC) are cultured as described above. .. Cells are harvested and washed twice with phosphate buffered saline and 1×106 cells (Calu-6) in growth media (without serum) are mixed with equal volume of BD MatrigelTM matrix (BD Bioscience, Franklin, N.J.), then injected subcutaneously into the flank of nude mice (CD-1 nu/nu, from Charles River Labs, Wilmington, Mass.).



    Similar Products

    calu 6 lung xenograft efficacy model  (ATCC)
    96
    ATCC calu 6 lung xenograft efficacy model
    Calu 6 Lung Xenograft Efficacy Model, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/calu+6+lung+xenograft+efficacy+model/Calu-6/us12558345-291-16-25
    Average 96 stars, based on 1 article reviews
    calu 6 lung xenograft efficacy model - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results